ALZCHEM GROUP AG (ACT.DE) Stock Fundamental Analysis

Europe • Frankfurt Stock Exchange • FRA:ACT • DE000A2YNT30

144 EUR
-3.4 (-2.31%)
Last: Feb 6, 2026, 05:29 PM
Fundamental Rating

7

Overall ACT gets a fundamental rating of 7 out of 10. We evaluated ACT against 68 industry peers in the Chemicals industry. ACT scores excellent points on both the profitability and health parts. This is a solid base for a good stock. ACT has a decent growth rate and is not valued too expensively. These ratings could make ACT a good candidate for quality investing.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

  • In the past year ACT was profitable.
  • ACT had a positive operating cash flow in the past year.
  • In the past 5 years ACT has always been profitable.
  • ACT had a positive operating cash flow in 4 of the past 5 years.
ACT.DE Yearly Net Income VS EBIT VS OCF VS FCFACT.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M 100M

1.2 Ratios

  • ACT's Return On Assets of 10.49% is amongst the best of the industry. ACT outperforms 95.59% of its industry peers.
  • The Return On Equity of ACT (26.47%) is better than 97.06% of its industry peers.
  • ACT has a Return On Invested Capital of 13.45%. This is amongst the best in the industry. ACT outperforms 94.12% of its industry peers.
  • ACT had an Average Return On Invested Capital over the past 3 years of 12.06%. This is significantly above the industry average of 6.72%.
  • The last Return On Invested Capital (13.45%) for ACT is above the 3 year average (12.06%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 10.49%
ROE 26.47%
ROIC 13.45%
ROA(3y)8.81%
ROA(5y)7.86%
ROE(3y)22.87%
ROE(5y)25.91%
ROIC(3y)12.06%
ROIC(5y)10.63%
ACT.DE Yearly ROA, ROE, ROICACT.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

  • ACT's Profit Margin of 10.97% is amongst the best of the industry. ACT outperforms 85.29% of its industry peers.
  • ACT's Profit Margin has improved in the last couple of years.
  • ACT's Operating Margin of 15.93% is amongst the best of the industry. ACT outperforms 86.76% of its industry peers.
  • In the last couple of years the Operating Margin of ACT has grown nicely.
  • ACT has a better Gross Margin (66.55%) than 97.06% of its industry peers.
  • ACT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 15.93%
PM (TTM) 10.97%
GM 66.55%
OM growth 3Y17.53%
OM growth 5Y12.4%
PM growth 3Y14.29%
PM growth 5Y15.31%
GM growth 3Y2.01%
GM growth 5Y1.44%
ACT.DE Yearly Profit, Operating, Gross MarginsACT.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), ACT is creating value.
  • The number of shares outstanding for ACT has been reduced compared to 1 year ago.
  • The number of shares outstanding for ACT has been reduced compared to 5 years ago.
  • The debt/assets ratio for ACT has been reduced compared to a year ago.
ACT.DE Yearly Shares OutstandingACT.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ACT.DE Yearly Total Debt VS Total AssetsACT.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

  • ACT has an Altman-Z score of 4.91. This indicates that ACT is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 4.91, ACT belongs to the top of the industry, outperforming 88.24% of the companies in the same industry.
  • The Debt to FCF ratio of ACT is 1.32, which is an excellent value as it means it would take ACT, only 1.32 years of fcf income to pay off all of its debts.
  • With an excellent Debt to FCF ratio value of 1.32, ACT belongs to the best of the industry, outperforming 94.12% of the companies in the same industry.
  • ACT has a Debt/Equity ratio of 0.16. This is a healthy value indicating a solid balance between debt and equity.
  • ACT has a better Debt to Equity ratio (0.16) than 73.53% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 1.32
Altman-Z 4.91
ROIC/WACC1.85
WACC7.29%
ACT.DE Yearly LT Debt VS Equity VS FCFACT.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

  • A Current Ratio of 2.87 indicates that ACT has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 2.87, ACT belongs to the top of the industry, outperforming 82.35% of the companies in the same industry.
  • ACT has a Quick Ratio of 1.77. This is a normal value and indicates that ACT is financially healthy and should not expect problems in meeting its short term obligations.
  • ACT has a Quick ratio of 1.77. This is amongst the best in the industry. ACT outperforms 82.35% of its industry peers.
Industry RankSector Rank
Current Ratio 2.87
Quick Ratio 1.77
ACT.DE Yearly Current Assets VS Current LiabilitesACT.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • ACT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.12%, which is quite impressive.
  • The Earnings Per Share has been growing by 24.60% on average over the past years. This is a very strong growth
  • Looking at the last year, ACT shows a small growth in Revenue. The Revenue has grown by 1.05% in the last year.
  • Measured over the past years, ACT shows a quite strong growth in Revenue. The Revenue has been growing by 8.06% on average per year.
EPS 1Y (TTM)24.12%
EPS 3Y25.02%
EPS 5Y24.6%
EPS Q2Q%31.66%
Revenue 1Y (TTM)1.05%
Revenue growth 3Y9.49%
Revenue growth 5Y8.06%
Sales Q2Q%6.46%

3.2 Future

  • Based on estimates for the next years, ACT will show a very strong growth in Earnings Per Share. The EPS will grow by 20.26% on average per year.
  • The Revenue is expected to grow by 6.02% on average over the next years.
EPS Next Y21.07%
EPS Next 2Y12.7%
EPS Next 3Y18.06%
EPS Next 5Y20.26%
Revenue Next Year2.51%
Revenue Next 2Y5.13%
Revenue Next 3Y8.61%
Revenue Next 5Y6.02%

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ACT.DE Yearly Revenue VS EstimatesACT.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M
ACT.DE Yearly EPS VS EstimatesACT.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 23.61, the valuation of ACT can be described as rather expensive.
  • Compared to the rest of the industry, the Price/Earnings ratio of ACT is on the same level as its industry peers.
  • ACT is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.67, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 22.26, ACT is valued on the expensive side.
  • The rest of the industry has a similar Price/Forward Earnings ratio as ACT.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.20, ACT is valued at the same level.
Industry RankSector Rank
PE 23.61
Fwd PE 22.26
ACT.DE Price Earnings VS Forward Price EarningsACT.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as ACT.
  • ACT's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 41.9
EV/EBITDA 12.63
ACT.DE Per share dataACT.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • ACT's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The excellent profitability rating of ACT may justify a higher PE ratio.
  • ACT's earnings are expected to grow with 18.06% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.12
PEG (5Y)0.96
EPS Next 2Y12.7%
EPS Next 3Y18.06%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. Dividend

5.1 Amount

  • ACT has a Yearly Dividend Yield of 1.14%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 2.28, ACT has a dividend in line with its industry peers.
  • ACT's Dividend Yield is slightly below the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 1.14%

5.2 History

  • The dividend of ACT has a limited annual growth rate of 6.00%.
Dividend Growth(5Y)6%
Div Incr Years5
Div Non Decr Years5
ACT.DE Yearly Dividends per shareACT.DE Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

  • 49.16% of the earnings are spent on dividend by ACT. This is a bit on the high side, but may be sustainable.
  • The dividend of ACT is growing, but earnings are growing more, so the dividend growth is sustainable.
DP49.16%
EPS Next 2Y12.7%
EPS Next 3Y18.06%
ACT.DE Yearly Income VS Free CF VS DividendACT.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M
ACT.DE Dividend Payout.ACT.DE Dividend Payout, showing the Payout Ratio.ACT.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ALZCHEM GROUP AG

FRA:ACT (2/6/2026, 5:29:57 PM)

144

-3.4 (-2.31%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)10-30
Earnings (Next)02-27
Inst Owners40.91%
Inst Owner ChangeN/A
Ins Owners28%
Ins Owner ChangeN/A
Market Cap1.47B
Revenue(TTM)563.86M
Net Income(TTM)61.84M
Analysts86
Price Target180.48 (25.33%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.14%
Yearly Dividend1.2
Dividend Growth(5Y)6%
DP49.16%
Div Incr Years5
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.6%
PT rev (3m)11.74%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)1.34%
EPS NY rev (3m)3.08%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.37%
Valuation
Industry RankSector Rank
PE 23.61
Fwd PE 22.26
P/S 2.6
P/FCF 41.9
P/OCF 10.07
P/B 6.27
P/tB 6.37
EV/EBITDA 12.63
EPS(TTM)6.1
EY4.24%
EPS(NY)6.47
Fwd EY4.49%
FCF(TTM)3.44
FCFY2.39%
OCF(TTM)14.3
OCFY9.93%
SpS55.39
BVpS22.95
TBVpS22.6
PEG (NY)1.12
PEG (5Y)0.96
Graham Number56.13
Profitability
Industry RankSector Rank
ROA 10.49%
ROE 26.47%
ROCE 18.66%
ROIC 13.45%
ROICexc 16.12%
ROICexgc 16.26%
OM 15.93%
PM (TTM) 10.97%
GM 66.55%
FCFM 6.21%
ROA(3y)8.81%
ROA(5y)7.86%
ROE(3y)22.87%
ROE(5y)25.91%
ROIC(3y)12.06%
ROIC(5y)10.63%
ROICexc(3y)13.35%
ROICexc(5y)11.55%
ROICexgc(3y)13.5%
ROICexgc(5y)11.66%
ROCE(3y)16.73%
ROCE(5y)14.74%
ROICexgc growth 3Y25.57%
ROICexgc growth 5Y18.04%
ROICexc growth 3Y25.41%
ROICexc growth 5Y17.9%
OM growth 3Y17.53%
OM growth 5Y12.4%
PM growth 3Y14.29%
PM growth 5Y15.31%
GM growth 3Y2.01%
GM growth 5Y1.44%
F-Score6
Asset Turnover0.96
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 1.32
Debt/EBITDA 0.33
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 125.34%
Profit Quality 56.58%
Current Ratio 2.87
Quick Ratio 1.77
Altman-Z 4.91
F-Score6
WACC7.29%
ROIC/WACC1.85
Cap/Depr(3y)118.98%
Cap/Depr(5y)119.68%
Cap/Sales(3y)5.65%
Cap/Sales(5y)6.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.12%
EPS 3Y25.02%
EPS 5Y24.6%
EPS Q2Q%31.66%
EPS Next Y21.07%
EPS Next 2Y12.7%
EPS Next 3Y18.06%
EPS Next 5Y20.26%
Revenue 1Y (TTM)1.05%
Revenue growth 3Y9.49%
Revenue growth 5Y8.06%
Sales Q2Q%6.46%
Revenue Next Year2.51%
Revenue Next 2Y5.13%
Revenue Next 3Y8.61%
Revenue Next 5Y6.02%
EBIT growth 1Y16.7%
EBIT growth 3Y28.68%
EBIT growth 5Y21.47%
EBIT Next Year50.25%
EBIT Next 3Y28.31%
EBIT Next 5Y19.11%
FCF growth 1Y37.23%
FCF growth 3Y62.42%
FCF growth 5Y94.14%
OCF growth 1Y166.77%
OCF growth 3Y34.7%
OCF growth 5Y19.23%

ALZCHEM GROUP AG / ACT.DE FAQ

Can you provide the ChartMill fundamental rating for ALZCHEM GROUP AG?

ChartMill assigns a fundamental rating of 7 / 10 to ACT.DE.


What is the valuation status for ACT stock?

ChartMill assigns a valuation rating of 4 / 10 to ALZCHEM GROUP AG (ACT.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for ALZCHEM GROUP AG?

ALZCHEM GROUP AG (ACT.DE) has a profitability rating of 9 / 10.


Can you provide the financial health for ACT stock?

The financial health rating of ALZCHEM GROUP AG (ACT.DE) is 9 / 10.


What is the earnings growth outlook for ALZCHEM GROUP AG?

The Earnings per Share (EPS) of ALZCHEM GROUP AG (ACT.DE) is expected to grow by 21.07% in the next year.